Expert Perspective on Practice-Changing Advances in Induction Therapy for High-Risk AML in Older Patients

In this interactive program Jeffrey E. Lancet MD assesses optimal induction treatments for older patients with high-risk acute myeloid leukemia.

Share

Program Content

Activities

Downloadable Slideset
Expert Perspective on Practice-Changing Advances in Induction Therapy for High-Risk AML in Older Patients
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 28, 2017

Expires: February 27, 2018

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Jazz Pharmaceuticals Inc